Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD); Raising Numbers on Recent Progress in HCV
Go back to Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD); Raising Numbers on Recent Progress in HCV| Gilead Sciences (NASDAQ: GILD) | Delayed: 138.45 +0.09 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.36 | 52 Week High | $108.63 | |||
| Open | $138.36 | 52 Week Low | $71.39 | |||
| Day High | $139.49 | P/E | 76.49 | |||
| Day Low | $136.63 | EPS | $1.81 | |||
| Volume | 1,051,596 | |||||
